RU2666352C2 - Соединение с агонистической активностью в отношении рецепторов соматостатина и его фармацевтическое применение - Google Patents
Соединение с агонистической активностью в отношении рецепторов соматостатина и его фармацевтическое применение Download PDFInfo
- Publication number
- RU2666352C2 RU2666352C2 RU2016111659A RU2016111659A RU2666352C2 RU 2666352 C2 RU2666352 C2 RU 2666352C2 RU 2016111659 A RU2016111659 A RU 2016111659A RU 2016111659 A RU2016111659 A RU 2016111659A RU 2666352 C2 RU2666352 C2 RU 2666352C2
- Authority
- RU
- Russia
- Prior art keywords
- pyridinyl
- dichlorophenyl
- phenyl
- piperidinyl
- piperidinamine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- A61P5/08—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2013205027 | 2013-09-30 | ||
| JP2013-205027 | 2013-09-30 | ||
| JP2013-268902 | 2013-12-26 | ||
| JP2013268902 | 2013-12-26 | ||
| PCT/JP2014/075794 WO2015046482A1 (ja) | 2013-09-30 | 2014-09-29 | ソマトスタチン受容体作動活性を有する化合物およびその医薬用途 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| RU2016111659A RU2016111659A (ru) | 2017-11-13 |
| RU2016111659A3 RU2016111659A3 (hu) | 2018-03-20 |
| RU2666352C2 true RU2666352C2 (ru) | 2018-09-07 |
Family
ID=52743606
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2016111659A RU2666352C2 (ru) | 2013-09-30 | 2014-09-29 | Соединение с агонистической активностью в отношении рецепторов соматостатина и его фармацевтическое применение |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US9643951B2 (hu) |
| EP (1) | EP3053916B1 (hu) |
| JP (1) | JP6380402B2 (hu) |
| KR (1) | KR20160062023A (hu) |
| CN (1) | CN105593221B (hu) |
| AU (1) | AU2014325078B2 (hu) |
| BR (1) | BR112016007078A2 (hu) |
| CA (1) | CA2925651A1 (hu) |
| DK (1) | DK3053916T3 (hu) |
| ES (1) | ES2716151T3 (hu) |
| HK (1) | HK1223356A1 (hu) |
| HU (1) | HUE043374T2 (hu) |
| IL (1) | IL244813A0 (hu) |
| MX (1) | MX2016004088A (hu) |
| PH (1) | PH12016500573B1 (hu) |
| PL (1) | PL3053916T3 (hu) |
| PT (1) | PT3053916T (hu) |
| RU (1) | RU2666352C2 (hu) |
| SG (1) | SG11201602477YA (hu) |
| TW (1) | TWI628175B (hu) |
| WO (1) | WO2015046482A1 (hu) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HRP20221279T1 (hr) | 2016-07-14 | 2022-12-23 | Crinetics Pharmaceuticals, Inc. | Modulatori somatostatina i njihove uporabe |
| JPWO2018147300A1 (ja) * | 2017-02-08 | 2019-11-21 | 小野薬品工業株式会社 | ソマトスタチン受容体作動活性を有する化合物およびその医薬用途 |
| EP3596062A4 (en) | 2017-03-16 | 2020-08-26 | Crinetics Pharmaceuticals, Inc. | SOMATOSTAT IN MODULATORS AND USES THEREOF |
| US11028068B2 (en) | 2017-07-25 | 2021-06-08 | Crinetics Pharmaceuticals, Inc. | Somatostatin modulators and uses thereof |
| HUE059184T2 (hu) * | 2018-01-17 | 2022-10-28 | Crinetics Pharmaceuticals Inc | Szomatosztatin modulátorok elõállításának folyamata |
| WO2019157458A1 (en) * | 2018-02-12 | 2019-08-15 | Crinetics Pharmaceuticals, Inc. | Somatostatin modulators and uses thereof |
| WO2019240246A1 (ja) * | 2018-06-15 | 2019-12-19 | 小野薬品工業株式会社 | ピペリジノール誘導体の新規な塩および新規結晶形 |
| US10696689B2 (en) | 2018-09-18 | 2020-06-30 | Crinetics Pharmaceuticals, Inc. | Somatostatin modulators and uses thereof |
| PE20221402A1 (es) | 2019-08-14 | 2022-09-15 | Crinetics Pharmaceuticals Inc | Receptores agonistas no peptidicos de somatostatina tipo 5 y usos de los mismos |
| AU2021341936A1 (en) | 2020-09-09 | 2023-05-25 | Crinetics Pharmaceuticals, Inc. | Formulations of a somatostatin modulator |
| US11773076B2 (en) | 2021-02-17 | 2023-10-03 | Crinetics Pharmaceuticals, Inc. | Crystalline forms of a somatostatin modulator |
| CN116789674B (zh) * | 2022-08-24 | 2024-05-24 | 杭州高光制药有限公司 | Nlrp3炎性小体抑制剂 |
| WO2024089668A1 (en) * | 2022-10-28 | 2024-05-02 | Basecamp Bio Inc. | Somatostatin receptor 2 agonists and uses thereof |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998044921A1 (en) * | 1997-04-04 | 1998-10-15 | Merck & Co., Inc. | Somatostatin agonists |
| WO1999022735A1 (en) * | 1997-10-30 | 1999-05-14 | Merck & Co., Inc. | Somatostatin agonists |
| RU2355418C2 (ru) * | 2003-06-24 | 2009-05-20 | Новартис Аг | Фармацевтическая композиция |
| WO2010041054A1 (en) * | 2008-10-06 | 2010-04-15 | Cancer Research Technology Limited | Pyridine and pyrimidine based compounds as wnt signaling pathway inhibitors for the treatment of cancer |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1072649C (zh) | 1995-09-13 | 2001-10-10 | 武田药品工业株式会社 | 苯并氧杂吖庚因化合物,其生产方法和用途 |
| US6025372A (en) | 1997-04-04 | 2000-02-15 | Merck & Co., Inc. | Somatostatin agonists |
| AU766831B2 (en) | 1998-05-11 | 2003-10-23 | Takeda Pharmaceutical Company Limited | Oxyiminoalkanoic acid derivatives with hypoglycemic and hypolipidemic activity |
| AR035016A1 (es) | 1999-08-25 | 2004-04-14 | Takeda Chemical Industries Ltd | Composicion de azol promotor de produccion/secrecion de neurotrofina, compuesto prodroga del mismo, composicion farmaceutica que lo comprende y uso del mismo para preparar esta ultima. |
| CA2386517A1 (en) | 1999-10-07 | 2001-04-12 | Takeda Chemical Industries, Ltd. | Amine derivatives |
| PL356487A1 (en) | 1999-11-10 | 2004-06-28 | Takeda Chemical Industries, Ltd. | 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity |
| FR2802206B1 (fr) * | 1999-12-14 | 2005-04-22 | Sod Conseils Rech Applic | Derives de 4-aminopiperidine et leur utilisation en tant que medicament |
| CA2407149C (en) | 2000-04-28 | 2010-10-12 | Takeda Chemical Industries, Ltd. | Melanin-concentrating hormone antagonist |
| AU2001256733A1 (en) | 2000-05-16 | 2001-11-26 | Takeda Chemical Industries Ltd. | Melanin-concentrating hormone antagonist |
| WO2003042204A1 (fr) | 2001-10-19 | 2003-05-22 | Takeda Chemical Industries, Ltd. | Derive d'amine |
| WO2006010637A2 (en) * | 2004-07-30 | 2006-02-02 | Gpc Biotech Ag | Pyridinylamines |
| CN101258152A (zh) * | 2005-07-04 | 2008-09-03 | 阿斯利康(瑞典)有限公司 | 作为pde4抑制剂用于治疗炎症和免疫疾病的吡啶并嘧啶衍生物 |
| TW200726767A (en) | 2005-07-04 | 2007-07-16 | Astrazeneca Ab | Chemical compounds 2 |
| WO2008051272A2 (en) * | 2006-03-13 | 2008-05-02 | Merck & Co., Inc. | Somatostatin agonists |
| WO2008019967A2 (en) * | 2006-08-15 | 2008-02-21 | F. Hoffmann-La Roche Ag | Phenyl, pyridine and quinoline derivatives |
| US9630976B2 (en) | 2012-07-03 | 2017-04-25 | Ono Pharmaceutical Co., Ltd. | Compound having agonistic activity on somatostatin receptor, and use thereof for medical purposes |
-
2014
- 2014-09-29 CN CN201480053967.4A patent/CN105593221B/zh not_active Expired - Fee Related
- 2014-09-29 KR KR1020167008316A patent/KR20160062023A/ko not_active Application Discontinuation
- 2014-09-29 SG SG11201602477YA patent/SG11201602477YA/en unknown
- 2014-09-29 MX MX2016004088A patent/MX2016004088A/es unknown
- 2014-09-29 PL PL14847684T patent/PL3053916T3/pl unknown
- 2014-09-29 PT PT14847684T patent/PT3053916T/pt unknown
- 2014-09-29 AU AU2014325078A patent/AU2014325078B2/en not_active Ceased
- 2014-09-29 ES ES14847684T patent/ES2716151T3/es active Active
- 2014-09-29 US US15/025,739 patent/US9643951B2/en active Active
- 2014-09-29 WO PCT/JP2014/075794 patent/WO2015046482A1/ja active Application Filing
- 2014-09-29 TW TW103133704A patent/TWI628175B/zh not_active IP Right Cessation
- 2014-09-29 JP JP2015539407A patent/JP6380402B2/ja not_active Expired - Fee Related
- 2014-09-29 RU RU2016111659A patent/RU2666352C2/ru not_active IP Right Cessation
- 2014-09-29 CA CA2925651A patent/CA2925651A1/en not_active Abandoned
- 2014-09-29 HU HUE14847684A patent/HUE043374T2/hu unknown
- 2014-09-29 BR BR112016007078A patent/BR112016007078A2/pt not_active IP Right Cessation
- 2014-09-29 DK DK14847684.9T patent/DK3053916T3/en active
- 2014-09-29 EP EP14847684.9A patent/EP3053916B1/en active Active
-
2016
- 2016-03-29 PH PH12016500573A patent/PH12016500573B1/en unknown
- 2016-03-29 IL IL244813A patent/IL244813A0/en unknown
- 2016-10-04 HK HK16111532.4A patent/HK1223356A1/zh not_active IP Right Cessation
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998044921A1 (en) * | 1997-04-04 | 1998-10-15 | Merck & Co., Inc. | Somatostatin agonists |
| WO1999022735A1 (en) * | 1997-10-30 | 1999-05-14 | Merck & Co., Inc. | Somatostatin agonists |
| RU2355418C2 (ru) * | 2003-06-24 | 2009-05-20 | Новартис Аг | Фармацевтическая композиция |
| WO2010041054A1 (en) * | 2008-10-06 | 2010-04-15 | Cancer Research Technology Limited | Pyridine and pyrimidine based compounds as wnt signaling pathway inhibitors for the treatment of cancer |
Also Published As
| Publication number | Publication date |
|---|---|
| DK3053916T3 (en) | 2019-04-15 |
| JP6380402B2 (ja) | 2018-08-29 |
| US9643951B2 (en) | 2017-05-09 |
| MX2016004088A (es) | 2016-06-06 |
| PT3053916T (pt) | 2019-03-26 |
| CA2925651A1 (en) | 2015-04-02 |
| IL244813A0 (en) | 2016-05-31 |
| TW201602092A (zh) | 2016-01-16 |
| RU2016111659A3 (hu) | 2018-03-20 |
| JPWO2015046482A1 (ja) | 2017-03-09 |
| EP3053916B1 (en) | 2019-01-30 |
| WO2015046482A1 (ja) | 2015-04-02 |
| AU2014325078A1 (en) | 2016-04-21 |
| PL3053916T3 (pl) | 2019-06-28 |
| AU2014325078B2 (en) | 2018-10-25 |
| SG11201602477YA (en) | 2016-05-30 |
| KR20160062023A (ko) | 2016-06-01 |
| EP3053916A4 (en) | 2017-03-08 |
| RU2016111659A (ru) | 2017-11-13 |
| PH12016500573A1 (en) | 2016-07-04 |
| EP3053916A1 (en) | 2016-08-10 |
| BR112016007078A2 (pt) | 2017-12-12 |
| HUE043374T2 (hu) | 2019-08-28 |
| ES2716151T3 (es) | 2019-06-10 |
| US20160311794A1 (en) | 2016-10-27 |
| CN105593221A (zh) | 2016-05-18 |
| HK1223356A1 (zh) | 2017-07-28 |
| PH12016500573B1 (en) | 2016-07-04 |
| CN105593221B (zh) | 2017-09-22 |
| TWI628175B (zh) | 2018-07-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2666352C2 (ru) | Соединение с агонистической активностью в отношении рецепторов соматостатина и его фармацевтическое применение | |
| US10214540B2 (en) | Compound having agonistic activity on somatostatin receptor, and use thereof for medical purposes | |
| CN103403004B (zh) | 作为离子通道调节剂的吡咯并吡嗪-螺环哌啶酰胺 | |
| CN104136442B (zh) | 作为离子通道调节剂的吡喃‑螺环哌啶酰胺类 | |
| KR20190114986A (ko) | 소마토스타틴 수용체 작동 활성을 갖는 화합물 및 그 의약 용도 | |
| KR102306951B1 (ko) | 이온 채널의 조절제로서의 융합된 피페리딘 아미드 | |
| TW200523252A (en) | Pyridine compounds | |
| CN103517910A (zh) | 作为离子通道调节剂的吗啉-螺环哌啶酰胺 | |
| WO2016022742A1 (en) | Antidiabetic bicyclic compounds | |
| TW201625586A (zh) | 環己烯－１－基－吡啶－２－基－１ｈ－吡唑－４－羧酸衍生物及其作為可溶性鳥苷酸環化酶活化劑之用途 | |
| JP2020023490A (ja) | ソマトスタチン受容体作動活性を有する化合物を含有してなる医薬組成物 | |
| WO2019240246A1 (ja) | ピペリジノール誘導体の新規な塩および新規結晶形 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20200930 |